Revolution Medicines マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Mark Goldsmith
最高経営責任者
US$10.4m
報酬総額
| CEO給与比率 | 6.1% |
| CEO在任期間 | 10yrs |
| CEOの所有権 | 0.4% |
| 経営陣の平均在職期間 | 6.5yrs |
| 取締役会の平均在任期間 | 7.9yrs |
経営陣の近況
Recent updates
Calculating The Intrinsic Value Of Revolution Medicines, Inc. (NASDAQ:RVMD)
Sep 28
This Is Why Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Looks Appropriate
Jun 15Revolution Medicines: On Hold Pending A Lower Entry Point
Jun 04Revolution Medicines: An Expensive Shot At A Massive Market Opportunity
Apr 12Revolution Medicines Is Hard To Understand
Feb 01Here's Why We're Not Too Worried About Revolution Medicines' (NASDAQ:RVMD) Cash Burn Situation
Aug 09Some Analysts Just Cut Their Revolution Medicines, Inc. (NASDAQ:RVMD) Estimates
May 13We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth
Apr 02We're Hopeful That Revolution Medicines (NASDAQ:RVMD) Will Use Its Cash Wisely
Dec 20We're Not Very Worried About Revolution Medicines' (NASDAQ:RVMD) Cash Burn Rate
Sep 15Revolution Medicines promotes Jack Anders to CFO
Sep 02New Forecasts: Here's What Analysts Think The Future Holds For Revolution Medicines, Inc. (NASDAQ:RVMD)
Aug 10CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$567m |
| Jun 30 2024 | n/a | n/a | -US$519m |
| Mar 31 2024 | n/a | n/a | -US$484m |
| Dec 31 2023 | US$10m | US$631k | -US$436m |
| Sep 30 2023 | n/a | n/a | -US$331m |
| Jun 30 2023 | n/a | n/a | -US$296m |
| Mar 31 2023 | n/a | n/a | -US$259m |
| Dec 31 2022 | US$7m | US$607k | -US$249m |
| Sep 30 2022 | n/a | n/a | -US$245m |
| Jun 30 2022 | n/a | n/a | -US$224m |
| Mar 31 2022 | n/a | n/a | -US$208m |
| Dec 31 2021 | US$8m | US$581k | -US$187m |
| Sep 30 2021 | n/a | n/a | -US$169m |
| Jun 30 2021 | n/a | n/a | -US$143m |
| Mar 31 2021 | n/a | n/a | -US$126m |
| Dec 31 2020 | US$2m | US$554k | -US$110m |
| Sep 30 2020 | n/a | n/a | -US$95m |
| Jun 30 2020 | n/a | n/a | -US$85m |
| Mar 31 2020 | n/a | n/a | -US$71m |
| Dec 31 2019 | US$5m | US$504k | -US$62m |
| Sep 30 2019 | n/a | n/a | -US$57m |
| Dec 31 2018 | US$1m | US$490k | -US$49m |
報酬と市場: Markの 総報酬 ($USD 10.41M ) は、 US市場 ($USD 12.73M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Markの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Mark Goldsmith (62 yo)
10yrs
在職期間
US$10,411,247
報酬
Dr. Mark A. Goldsmith, M.D., Ph.D. is the Chief Executive Officer, President and Director of Revolution Medicines, Inc. since November 2014 and serves as its Chairman. Dr. Goldsmith served as a Venture Par...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Chairman | 10yrs | US$10.41m | 0.39% $ 37.4m | |
| Chief Financial Officer | 6.3yrs | US$3.05m | 0.029% $ 2.8m | |
| Chief Operating Officer | 6.1yrs | US$4.39m | 0.033% $ 3.1m | |
| President of Research & Development | 7.7yrs | US$4.39m | 0.11% $ 10.2m | |
| Executive Vice President of Development | 6.7yrs | US$3.23m | 0.015% $ 1.5m | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | データなし | データなし | |
| Academic Co-Founder & Member of Scientific Advisory Board | no data | データなし | データなし | |
| Academic Co-Founder & Member of Scientific Advisory Board | 7.9yrs | データなし | データなし | |
| Chief Information Officer | no data | データなし | データなし | |
| Chief Scientific Officer | 1.3yrs | データなし | データなし | |
| Senior Director of Corporate Communications & Investor Relations | no data | データなし | データなし | |
| Senior VP | 2.2yrs | データなし | 0.0032% $ 309.1k |
6.5yrs
平均在職期間
53yo
平均年齢
経験豊富な経営陣: RVMDの経営陣は経験豊富で経験豊富です（平均在職期間は6.5年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Chairman | 10yrs | US$10.41m | 0.39% $ 37.4m | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | データなし | データなし | |
| Academic Co-Founder & Member of Scientific Advisory Board | 8.4yrs | データなし | データなし | |
| Academic Co-Founder & Member of Scientific Advisory Board | 7.9yrs | データなし | データなし | |
| Senior Advisor & Member of Scientific Advisory Board | 7.9yrs | データなし | データなし | |
| Lead Independent Director | 10yrs | US$510.63k | 1.39% $ 133.1m | |
| Senior Advisor & Member of Scientific Advisory Board | 8.4yrs | データなし | データなし | |
| Senior Advisor & Member of Scientific Advisory Board | 7.9yrs | データなし | データなし | |
| Independent Director | 2.3yrs | US$489.99k | 0.036% $ 3.5m | |
| Independent Director | 6.7yrs | データなし | データなし | |
| Independent Director | 9.7yrs | US$483.78k | 0.025% $ 2.4m | |
| Senior Advisor & Member of Scientific Advisory Board | 7.9yrs | データなし | データなし |
7.9yrs
平均在職期間
52yo
平均年齢
経験豊富なボード: RVMDの 取締役会 は 経験豊富 であると考えられます ( 7.9年の平均在任期間)。